- NSE
- AUROPHARMA
- BSE
- 524804
- ISIN
- INE406A01037
AUROBINDO PHARMA
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹1,855.30
+₹55.30 (+3.07%)
NSE close ·
AUROBINDO PHARMA closed at ₹1,855.30 on 9 Nov 2026, up 3.07% on the day, and is up 65.09% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹1,121.70 to ₹1,855.30.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹1,06,750 Cr
- P/E (TTM)
- 26.9
- Industry P/E
- 35.5
- EPS (TTM)
- ₹68.96
- P/B
- 2.71
- Book value
- ₹684.77
- ROE
- 10.1%
- ROCE
- 13.1%
- Debt/equity
- 0.21
- Operating margin
- 14.9%
- Net margin
- 10.8%
- Dividend yield
- 0.00%
Market cap, P/E, P/B and yield at the 9 Nov 2026 close. TTM: four quarters to 30 Sep 2026 (consolidated). Balance sheet 30 Sep 2026. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Growth | 1Y | 3Y CAGR |
|---|---|---|
| Revenue | +13.98% | +11.07% |
| Net profit | +16.54% | +19.80% |
Trailing twelve months against the same period 1 and 3 years earlier (3Y as a yearly rate); consolidated.
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Sep 2026 | ₹10,432 Cr | ₹1,124 Cr | +32.51% | ₹19.57 |
| Jun 2026 | ₹9,415 Cr | ₹1,032 Cr | +25.22% | ₹17.86 |
| Mar 2026 | ₹8,970 Cr | ₹921 Cr | +1.99% | ₹15.86 |
| Dec 2025 | ₹8,834 Cr | ₹910 Cr | +7.60% | ₹15.67 |
| Sep 2025 | ₹8,406 Cr | ₹848 Cr | +3.82% | ₹14.61 |
| Jun 2025 | ₹7,973 Cr | ₹824 Cr | −10.24% | ₹14.20 |
| Mar 2025 | ₹8,517 Cr | ₹903 Cr | −0.50% | ₹15.56 |
| Dec 2024 | ₹8,136 Cr | ₹846 Cr | −10.04% | ₹14.56 |
Armor risk check
AUROBINDO PHARMA moves about 1.8× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is AUROBINDO PHARMA's share price today?
AUROBINDO PHARMA (NSE: AUROPHARMA) closed at ₹1,855.30 on 9 Nov 2026, up 3.07% from the previous close of ₹1,800.00. It traded between ₹1,800.70 and ₹1,856.10 that day.
What are AUROBINDO PHARMA's 52-week high and low?
Over the last 52 weeks AUROBINDO PHARMA traded between ₹1,106.00 and ₹1,856.10, adjusted for splits and bonuses.
What are AUROBINDO PHARMA's NSE symbol, BSE code and ISIN?
AUROBINDO PHARMA has NSE symbol AUROPHARMA, BSE code 524804, ISIN INE406A01037.
How has AUROBINDO PHARMA performed over 1, 3 and 5 years?
AUROBINDO PHARMA's share price return: 1Y +65.09%, 3Y +24.96% a year, 5Y +22.34% a year. Dividends are not included.
Does AUROBINDO PHARMA pay a dividend?
Yes. AUROBINDO PHARMA's latest dividend went ex on 11 Nov 2026: Interim · ₹7.00 per share.
What is AUROBINDO PHARMA's P/E ratio?
AUROBINDO PHARMA's P/E ratio is 26.9: the ₹1,855.30 close on 9 Nov 2026 over trailing twelve-month EPS of ₹68.96 (consolidated, four quarters to 30 Sep 2026).
What is AUROBINDO PHARMA's market cap?
AUROBINDO PHARMA's market cap is ₹1,06,750 Cr at the close on 9 Nov 2026.
Which sector is AUROBINDO PHARMA in?
AUROBINDO PHARMA is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how AUROBINDO PHARMA fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app